Fispemifene

DB06640InvestigationalSmall molecule

Investigated for use/treatment in male hormonal deficiencies/abnormalities.

Chemical structure of Fispemifene
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in male hormonal deficiencies/abnormalities.Curator reviewed
Formula / weight
C26H27ClO3 · 422.95 g/mol (avg)
Code names
HM-101 · HM-101A

Resolves to

Compound
UNII3VZ2833V08CAS341524-89-8ChEMBLCHEMBL2107341
Structure
InChIKeyNKZTZAQIKKGTDB-QPLCGJKRSA-NSMILESOCCOCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Fispemifene, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In